Groundbreaking new model for predicting vaccine efficacy and safety

May 14th, 2012
Disruptive Science and Technology, a breakthrough, highly innovative, peer-reviewed journal spearheaded by Editor-in-Chief Alan J. Russell, Ph.D., Highmark Distinguished Professor, Carnegie Mellon University, cultivates, harnesses, and explores how existing paradigms can be changed to improve human health, well-being, and productivity. Credit: ©2012 Mary Ann Liebert, Inc., publishers
Vaccine testing and development is an extremely lengthy and complex process that costs billions of dollars every year. In an effort to dramatically improve the speed and success of vaccine research and development, researchers have created an innovative biomimetic model of the human immune system known as the MIMIC® system. An article in the inaugural issue of Disruptive Science and Technology, a peer-reviewed journal published by Mary Ann Liebert, Inc., describes this artificial human immune system which can facilitate faster, more effective vaccine development. For a copy of the article "In vitro Biomimetic Model of the Human Immune System for Predictive Vaccine Assessments," please contact journalmarketing1@liebertpub.com.

"Our goal is to increase the likelihood of success within the clinic– to make better drugs and vaccines and get them into the marketplace and to the patients faster," says William Warren, PhD, Head of the VaxDesign Campus, Sanofi Pasteur. "This in vitro human immune system enables us to measure vaccine efficacy earlier and more predictably."

The MIMIC® platform represents a truly disruptive technology for the study of vaccines and other biologics with immunomodulatory potential, as it provides a novel in vitro model for evaluating human immune responses against candidate drugs, adjuvants, and vaccines. It has shown game-changing advantages over conventional approaches to safety and efficacy testing.

Provided by Mary Ann Liebert, Inc.

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

Genetic modification aids cancer drug discovery

Genetically modifying cancer cells can aid in clarifying new cancer drugs' mechanism of action, according to a new study by researchers at KU Leuven's Laboratory of Virology and Chemotherapy (Rega Institute).

Make your diet anti-inflammatory with a few easy changes

Use your search engine or explore a local bookstore, and you'll find a wide variety of anti-inflammatory diet books. This eating approach is promoted to reduce everything from heart disease to asthma, and often requires you ...

Getting enough sleep really isn't optional

The typical adult needs 7 to 7 1/2 hours of sleep each night, while for teenagers and young adults under 25 about 9 to 10 hours of sleep per night is recommended, says Ann Romaker, MD, director of the University ...